메뉴 건너뛰기
International Journal of Cardiology
Volumn 107, Issue 2, 2006, Pages 284-286
Partial myocardial fibrosis in hypertrophic cardiomyopathy demonstrated by 18F-fluoro-deoxyglucose positron emission tomography and multislice computed tomography [5]
Author keywords

18F fluoro deoxyglucose; Hypertrophic cardiomyopathy; Multislice computed tomography; Partial myocardial fibrosis
Indexed keywords

FLUORODEOXYGLUCOSE F 18;
EID: 30444438042     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.01.069     Document Type: Article
Times cited : (18)
References (6)
  • 1
    • 1842828916 scopus 로고    scopus 로고
    • P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy
    • O. Ozdemir P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy Int J Cardiol 94 2004 163 166
    • (2004) Int J Cardiol , vol.94 , pp. 163-166
    • Ozdemir, O.1
  • 2
    • 0038043150 scopus 로고    scopus 로고
    • Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population
    • P. Charron, J.F. Forissier, M.E. Amara, O. Dubourg, M. Desnos, and J.B. Bouhour Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population Int J Cardiol 90 2003 33 38
    • (2003) Int J Cardiol , vol.90 , pp. 33-38
    • Charron, P.1    Forissier, J.F.2    Amara, M.E.3    Dubourg, O.4    Desnos, M.5    Bouhour, J.B.6
  • 4
    • 0028275308 scopus 로고
    • Risk factors for systolic dysfunction and ventricular dilatation in hypertrophic cardiomyopathy
    • R. Bingisser, R. Candinas, J. Schneider, and O.M. Hess Risk factors for systolic dysfunction and ventricular dilatation in hypertrophic cardiomyopathy Int J Cardiol 44 1994 225 233
    • (1994) Int J Cardiol , vol.44 , pp. 225-233
    • Bingisser, R.1    Candinas, R.2    Schneider, J.3    Hess, O.M.4
  • 5
    • 0036146568 scopus 로고    scopus 로고
    • Characterization of myocardial hypertrophy by DNA content, PCNA expression and apoptotic index
    • L. Matturri, J. Milei, D.R. Grana, and A.M. Lavezzi Characterization of myocardial hypertrophy by DNA content, PCNA expression and apoptotic index Int J Cardiol 82 2002 33 39
    • (2002) Int J Cardiol , vol.82 , pp. 33-39
    • Matturri, L.1    Milei, J.2    Grana, D.R.3    Lavezzi, A.M.4
  • 6
    • 0038076143 scopus 로고    scopus 로고
    • Toward clinical assessment in hypertrophic cardiomyopathy with Gadolinium cardiovascular magnetic resonance
    • J.C. Moon, W.J. McKenna, and J.A. McCrohon Toward clinical assessment in hypertrophic cardiomyopathy with Gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1561-1567
    • Moon, J.C.1    McKenna, W.J.2    McCrohon, J.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.